Image

Global Saphenous Vein Grafts Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Saphenous Vein Grafts Market, By Applications (Coronary Artery Bypass Grafting (CABG), Arteriovenous (AV) Fistulas Access, Vascular Reconstruction), End User (Hospitals, Ambulatory Surgical Centers, Others) – Industry Trends and Forecast to 2029.

Saphenous Vein Grafts Market

Global Saphenous Vein Grafts Market Analysis and Size

Coronary bypass procedures are on the rise globally. Factually, more than 9.5 lakh people die of cardiovascular diseases annually. A wide number of medical products are available in the market that facilitate bypassing the infected or diseased blood vessels. According to the Centers for Disease Control and Prevention (CDC), around 8.5 million people in the U.S. had peripheral arterial diseases.

  • Data Bridge Market Research analyses that the saphenous vein grafts market is expected to undergo a CAGR of 5.40% during the forecast period. This indicates that the market value, which was USD 1.68 billion in 2021, would rocket up to USD 2.56 billion by 2029. “Hospitals” dominates the end user segment of the saphenous vein grafts market owing to the growing number of hospitals especially in the developing economies. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Saphenous Vein Grafts Market Definition

From the name itself, it is clear that saphenous vein grafts refers to the medical grafts that are used in the treatment of coronary artery bypass. The role of saphenous vein grafts is to direct the flow of blood from one area of the body to another by reconnecting blood vessels. The saphenous vein grafts are used for a wide range of vascular diseases.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Applications (Coronary Artery Bypass Grafting (CABG), Arteriovenous (AV) Fistulas Access, Vascular Reconstruction), End User (Hospitals, Ambulatory Surgical Centers, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

CryoLife, Inc. (US), LifeNet Health (US), LeMaitre Vascular, Inc. (US), Boston Scientific Corporation (US), Hancock Jaffe Laboratories, Inc. (US), KARL STORZ SE & Co. KG (Germany), Getinge AB (Sweden), Medtronic (Ireland), Terumo Systems Corporation (Japan), Novartis AG (Switzerland), Pfizer Inc. (US), Merck & Co., Inc. (Germany), Novo Nordisk A/S (Denmark), Amgen Inc. (US), AstraZeneca (UK), F. Hoffmann-La Roche Ltd (Switzerland), Sanofi (France), Johnson & Johnson Services, Inc. (US), GlaxoSmithKline plc (UK), Bayer AG (Germany), Bristol-Myers Squibb Company (US), Abbott (US), Bausch & Lomb Incorporated (US), BD (US) and AbbVie Inc. (US)    

Market Opportunities

  • Growth in the awareness about the benefits of maintaining personal health
  • Increasing incidence rate of vascular diseases  
  • Rising research and development opportunities

Saphenous Vein Grafts Market Dynamics

Drivers

  • Rising prevalence of conditions

Growing incidence rate of several cardiovascular conditions globally is one of the major factors fostering the growth of the market. Increasing incidence rate of peripheral artery disease is directly propelling the market growth rate. More than 10 million cases per year are witnessed in India and this condition may prevail for lifetime if not treated properly.    

  • Research and development proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted for the advancements in medical technologies and devices is also bolstering the market growth rate.

  • Growing investment for healthcare facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.  

Opportunities

Furthermore, upsurge in the public-private funding for target research activities, high stress levels in young people and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, unhealthy lifestyle of individuals, rising internet penetration rate, growing rate of smoking ongoing product development and commercialization and increasing per capita expenditure on health care will further expand the market's growth rate in the future. 

Restraints/Challenges Global Saphenous Vein Grafts Market

On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities, uneven distribution of medical services, dearth of skilled medical professionals, rising geriatric population base and dearth of awareness in the backward economies are expected to obstruct market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, high costs associated with the procedure, limited insurance coverage and regulatory compliance, rising number of product failure and product recalls and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.

This saphenous vein grafts market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the saphenous vein grafts market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Saphenous Vein Grafts Market

The COVID-19 pandemic essentially affected the market. This is because of the fact that majority of the healthcare resources were directed towards meeting the demand arising out of COVID-19 patients. Postponement of non-elective surgeries and non-essential healthcare procedures has further derailed the market growth rate in this pandemic period. Further, restrictions imposed on travel owing to the lockdown regulations further challenged the market growth rate in this period. However, the post pandemic period will help to generate profits and revenues. 

Recent Development

  • In February 2021, Aesculap, Inc. completed the asset acquisition of Dextera Surgical Inc. Through this acquisition, Aesculap expanded its product portfolio by adding innovative MicroCutter 5/80 staplers, PAS-Port proximal anastomosis system and innovative devices for CABG surgery to its existing medical devices which contributed in the company’s growth in the cardiothoracic surgery market which is expected to impel the global CABG market growth throughout the forecast period. 

Global Saphenous Vein Grafts Market Scope

The saphenous vein grafts market is segmented on the basis of application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application  

  • Coronary Artery Bypass Grafting (CABG)
  • Arteriovenous (AV) Fistulas Access
  • Vascular Reconstruction

Based on application, saphenous vein grafts market is segmented into coronary artery bypass grafting (CABG), arteriovenous (AV) fistulas access and vascular reconstruction. 

End user

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Saphenous vein grafts market has also been segmented on the basis of end user into hospitals, ambulatory surgical centers and others.

Saphenous Vein Grafts Market Regional Analysis/Insights

The saphenous vein grafts market is analysed and market size insights and trends are provided by country, application and end user as referenced above.

The countries covered in the saphenous vein grafts market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the saphenous vein grafts market because of the strong base of healthcare facilities, widespread utilization of medications, increasing occurrence of lifestyle diseases, increasing consciousness regarding the essence of maintaining good health and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, increasing occurrence of lifestyle diseases, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The saphenous vein grafts market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for saphenous vein grafts market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the saphenous vein grafts market. The data is available for historic period 2010-2020.

Competitive Landscape and Saphenous Vein Grafts Market Share Analysis

The saphenous vein grafts market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to saphenous vein grafts market.

Some of the major players operating in the saphenous vein grafts market are:

  • CryoLife, Inc. (US)
  • LifeNet Health (US)
  • LeMaitre Vascular, Inc. (US)
  • Boston Scientific Corporation (US)
  • Hancock Jaffe Laboratories, Inc. (US)
  • KARL STORZ SE & Co. KG (Germany)
  • Getinge AB (Sweden)
  • Medtronic (Ireland)
  • Terumo Systems Corporation (Japan)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (US)
  • Merck & Co., Inc. (Germany)
  • Novo Nordisk A/S (Denmark)
  • Amgen Inc. (US)
  • AstraZeneca (UK)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Sanofi (France)
  • Johnson & Johnson Services, Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Bayer AG (Germany)
  • Bristol-Myers Squibb Company (US)
  • Abbott (US)
  • Bausch & Lomb Incorporated (US)
  • BD (US)
  • AbbVie Inc. (US)   

Research Methodology : Global Saphenous Vein Grafts Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-saphenous-vein-grafts-market


SKU-
Why Choose Us


Frequently Asked Questions

The Saphenous Vein Grafts Market Value is expected USD 2.56 billion by 2029.
The Saphenous Vein Grafts Market is Projected to Grow at a CAGR of 5.40% During the Forecast Period of 2022 to 2029.
CryoLife, Inc. (US), LifeNet Health (US), LeMaitre Vascular, Inc. (US), Boston Scientific Corporation (US), Hancock Jaffe Laboratories, Inc. (US), KARL STORZ SE & Co. KG (Germany), Getinge AB (Sweden), Medtronic (Ireland), Terumo Systems Corporation (Japan), Novartis AG (Switzerland), Pfizer Inc. (US), Merck & Co., Inc. (Germany), Novo Nordisk A/S (Denmark), Amgen Inc. (US), AstraZeneca (UK), F. Hoffmann-La Roche Ltd (Switzerland), Sanofi (France), Johnson & Johnson Services, Inc. (US), GlaxoSmithKline plc (UK), Bayer AG (Germany), Bristol-Myers Squibb Company (US), Abbott (US), Bausch & Lomb Incorporated (US), BD (US) and AbbVie Inc. (US) are the major Companies Operating in Saphenous Vein Grafts Market.
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The Saphenous Vein Grafts Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.